Apollo Hospitals Enterprise Ltd Q2 FY27 results (latest), Jul–Sep 2026 →Revenue ₹7,615 Cr +23% YoYSee revenue, profit and what management said. You are viewing Q4 FY26.
AH

Apollo Hospitals Enterprise Ltd

Q4 FY26Healthcare Services

Apollo Hospitals Enterprise Q4 FY26 earnings call: Revenue & Margins

Q4 FY26 earnings call: what management said on revenue, margins and capex.

Revenue
₹6,606Cr
+18.1% YoY
+2% QoQ
Net profit
₹551Cr
+33.1% YoY
+6.8% QoQ
Margin
15%
+1 pp YoY
0 pp QoQ

What the Q4 FY26 call signalled

3 of 3 strong

RevenueGood growth
MarginMargins slightly up
CapexCapex planned
Price₹8,878
Market cap₹1.2L Cr
P/E59.4

The short version

Apollo HealthCo aims for INR 25,000 crore revenue run rate by Q4 FY27, growing from INR 19,000 crore pro forma basis in FY26, targeting 21% growth. Company expects overall Healthcare Services to deliver mid-teen revenue growth in FY27 with improved margins by at least 100 bps in established units.

From Apollo Hospitals Enterprise Ltd's Q4 FY26 earnings-call transcript · updated 25 Aug 2026.

Revenue & Sales Performance

Good growth
  • Apollo HealthCo aims for INR 25,000 crore revenue run rate by Q4 FY27, growing from INR 19,000 crore pro forma basis in FY26, targeting 21% growth.
  • 30% growth currently driven by top 5 markets; expansion planned into new markets.
  • Pharmacy business acquiring 200,000-220,000 new customers monthly, expected to increase with 7,500 outlets synergy.
  • Diagnostics business growing 25%-30%, with plans to further grow and strengthen through integration.
  • Hospital services targeting mid-teen revenue growth in FY27; expecting gradual revenue acceleration and better asset utilization.
  • New hospitals adding about 1,400 beds, with phased commissioning; 500-600 beds expected operational by mid-FY27.

2 more points from Apollo Hospitals Enterprise Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Apollo Hospitals Enterprise Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

Capex planned
  • Growth capex for hospitals is expected to continue at around INR 550 crore annually, considered fully redeployable for expansion.
  • INR 1,980 crore capex is planned for FY27 to commission 1,000 new beds.
  • Four new hospitals operationalized in FY26 with 855 beds capacity; 185 beds operationalized, remaining 670 beds to be commissioned over next 12 months.
  • Two more hospitals (Sarjapur and Gurugram) expected to be commissioned in the next two quarters, adding up to approximately 1,400 beds in metro markets by FY28.
  • Investments ongoing in clinical leadership (oncology, robotics, advanced care), technology, and digital health to improve consumer engagement and operational integration.

2 more points from Apollo Hospitals Enterprise Ltd's call on capex

Create a free account to keep reading this call

Top-ranked in Healthcare Services

Ranked on what management guided this quarter

Guidance-ranked
Rev 1Mar 1
Rev 1Mar 3
3
Rev 2Mar 1
4
Rev 2Mar 1
5
Rev 2Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Apollo Hospitals Enterprise Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

See what Apollo Hospitals Enterprise Ltd said on order book & pipeline — free account, 30 seconds.

Apollo Hospitals Enterprise Ltd — Quarterly revenue & net profit

Revenue Net profit
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

Apollo Hospitals Enterprise Ltd Q4 FY26 results — key figures

Apollo Hospitals Enterprise Ltd Q4 FY26 reported results vs Q4 FY25, ₹ crore
₹ CrQ4 FY26Q4 FY25YoYQ3 FY26QoQ
Revenue6,6065,592+18.1%6,477+2%
Operating profit (EBITDA)1,011770+31.3%965+4.8%
Operating margin15%14%+1 pp15%0 pp
Profit before tax722516+39.9%682+5.9%
Net profit (PAT)551414+33.1%516+6.8%
EPS (₹)36.8127.10+35.8%34.93+5.4%

Source: reported quarterly figures (Screener), ₹ crore.

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹7.6K Cr, net profit ₹660 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Healthcare Services this season

  • Suven Life Sciences (Q4 FY26)

    The provided pages of the investor presentation do not report any revenue, sales, or volume figures for the quarter. Key investor presentation takeaways from Su

  • Invicta Diagnostic (Q4 FY26)

    Invicta Diagnostic Limited is deploying IPO funds (INR 21 crores raised) primarily towards: . Key concall takeaways from Invicta Diagnostic's Q4 FY26 earnings…

  • KMC Speciality (Q4 FY26)

    Q4 FY’26 Revenue from Operations: INR 82.3 Cr, up 35.0% YoY from INR 60.9 Cr in Q4 FY’25 (Page 20) . Key concall takeaways from KMC Speciality Hospitals…

  • Star Imaging (Q4 FY26)

    Capex planned for FY27 is around INR 20 to 25 crores, mainly towards new centres and equipment. Key concall takeaways from Star Imaging's Q4 FY26 earnings call…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Apollo Hospitals Enterprise Ltd and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Apollo Hospitals Enterprise Ltd Q4 FY26 results?

Apollo HealthCo aims for INR 25,000 crore revenue run rate by Q4 FY27, growing from INR 19,000 crore pro forma basis in FY26, targeting 21% growth. Company expects overall Healthcare Services to deliver mid-teen revenue growth in FY27 with improved margins by at least 100 bps in established units.

What is Apollo Hospitals Enterprise Ltd share price analysis?

Apollo Hospitals Enterprise Ltd currently shows a moderate growth signal based on ranking data. The stock trades at a P/E of 59.4 with a market cap of ₹124,992 Cr. Investors should review the full earnings analysis for detailed insights.

Is Apollo Hospitals Enterprise Ltd planning capital expenditure?

Growth capex for hospitals is expected to continue at around INR 550 crore annually, considered fully redeployable for expansion.

Keep Apollo Hospitals Enterprise Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.